BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37889486)

  • 1. Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial.
    Pencina KM; Travison TG; Artz AS; Lincoff AM; Nissen SE; Flevaris P; Chan A; Li X; Diegel SA; Wannemuehler K; Bhasin S
    JAMA Netw Open; 2023 Oct; 6(10):e2340030. PubMed ID: 37889486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial.
    Bhasin S; Lincoff AM; Nissen SE; Wannemuehler K; McDonnell ME; Peters AL; Khan N; Snabes MC; Li X; Li G; Buhr K; Pencina KM; Travison TG
    JAMA Intern Med; 2024 Apr; 184(4):353-362. PubMed ID: 38315466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial.
    Bhasin S; Travison TG; Pencina KM; O'Leary M; Cunningham GR; Lincoff AM; Nissen SE; Lucia MS; Preston MA; Khera M; Khan N; Snabes MC; Li X; Tangen CM; Buhr KA; Thompson IM
    JAMA Netw Open; 2023 Dec; 6(12):e2348692. PubMed ID: 38150256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism.
    Pencina KM; Travison TG; Cunningham GR; Lincoff AM; Nissen SE; Khera M; Miller MG; Flevaris P; Li X; Wannemuehler K; Bhasin S
    J Clin Endocrinol Metab; 2024 Jan; 109(2):569-580. PubMed ID: 37589949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressive Syndromes in Men with Hypogonadism in the TRAVERSE Trial: Response to Testosterone Replacement Therapy.
    Bhasin S; Seidman S; Travison TG; Pencina KM; Lincoff AM; Nissen SE; Miller MG; Flevaris P; Li X; Wannemuehler K; Pope HG
    J Clin Endocrinol Metab; 2024 Jan; ():. PubMed ID: 38205962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of Iron Flux during Testosterone-Mediated Erythropoiesis in Older Men with Unexplained or Iron-Deficiency Anemia.
    Artz AS; Stephens-Shields AJ; Bhasin S; Ellenberg SS; Cohen HJ; Snyder PJ
    J Clin Endocrinol Metab; 2020 Nov; 105(11):3396-403. PubMed ID: 32785689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial.
    Roy CN; Snyder PJ; Stephens-Shields AJ; Artz AS; Bhasin S; Cohen HJ; Farrar JT; Gill TM; Zeldow B; Cella D; Barrett-Connor E; Cauley JA; Crandall JP; Cunningham GR; Ensrud KE; Lewis CE; Matsumoto AM; Molitch ME; Pahor M; Swerdloff RS; Cifelli D; Hou X; Resnick SM; Walston JD; Anton S; Basaria S; Diem SJ; Wang C; Schrier SL; Ellenberg SS
    JAMA Intern Med; 2017 Apr; 177(4):480-490. PubMed ID: 28241237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study.
    Bhasin S; Lincoff AM; Basaria S; Bauer DC; Boden WE; Cunningham GR; Davey D; Dubcenco E; Fukumoto S; Garcia M; Granger CB; Kalahasti V; Khera M; Miller MG; Mitchell LM; O'Leary MP; Pencina KM; Snyder PJ; Thompson IM; Travison TG; Wolski K; Nissen SE;
    Am Heart J; 2022 Mar; 245():41-50. PubMed ID: 34871580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Safety of Testosterone-Replacement Therapy.
    Lincoff AM; Bhasin S; Flevaris P; Mitchell LM; Basaria S; Boden WE; Cunningham GR; Granger CB; Khera M; Thompson IM; Wang Q; Wolski K; Davey D; Kalahasti V; Khan N; Miller MG; Snabes MC; Chan A; Dubcenco E; Li X; Yi T; Huang B; Pencina KM; Travison TG; Nissen SE;
    N Engl J Med; 2023 Jul; 389(2):107-117. PubMed ID: 37326322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
    Lundy SD; Parekh NV; Shoskes DA
    J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).
    Bhattacharya RK; Khera M; Blick G; Kushner H; Miner MM
    Clin Interv Aging; 2012; 7():321-30. PubMed ID: 22956867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone Treatment and Fractures in Men with Hypogonadism.
    Snyder PJ; Bauer DC; Ellenberg SS; Cauley JA; Buhr KA; Bhasin S; Miller MG; Khan NS; Li X; Nissen SE
    N Engl J Med; 2024 Jan; 390(3):203-211. PubMed ID: 38231621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.
    Budoff MJ; Ellenberg SS; Lewis CE; Mohler ER; Wenger NK; Bhasin S; Barrett-Connor E; Swerdloff RS; Stephens-Shields A; Cauley JA; Crandall JP; Cunningham GR; Ensrud KE; Gill TM; Matsumoto AM; Molitch ME; Nakanishi R; Nezarat N; Matsumoto S; Hou X; Basaria S; Diem SJ; Wang C; Cifelli D; Snyder PJ
    JAMA; 2017 Feb; 317(7):708-716. PubMed ID: 28241355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression).
    Shores MM; Kivlahan DR; Sadak TI; Li EJ; Matsumoto AM
    J Clin Psychiatry; 2009 Jul; 70(7):1009-16. PubMed ID: 19653976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could Testosterone Replacement Therapy in Hypogonadal Men Ameliorate Anemia, a Cardiovascular Risk Factor? An Observational, 54-Week Cumulative Registry Study.
    Zhang LT; Shin YS; Kim JY; Park JK
    J Urol; 2016 Apr; 195(4 Pt 1):1057-64. PubMed ID: 26519655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone replacement therapy of opioid-induced male hypogonadism improved body composition but not pain perception: a double-blind, randomized, and placebo-controlled trial.
    Glintborg D; Vaegter HB; Christensen LL; Bendix E; Graven-Nielsen T; Andersen PG; Andersen M
    Eur J Endocrinol; 2020 Jun; 182(6):539-548. PubMed ID: 32213659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.